By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


EUSA Pharma 

New York City  New York    U.S.A.
Phone: Fax:



Start Up

Company News
Jazz Pharmaceuticals, plc (JAZZ) Completes EUSA Pharma Acquisition 6/12/2012 11:06:44 AM
Jazz Pharmaceuticals, Inc. (JAZZ) Buying EUSA Pharma for Up to $700 Million 4/27/2012 7:34:48 AM
Alize Pharma Licenses its ASPAREC(R) Therapy for Treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma 2/2/2012 10:59:33 AM
EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC(R) for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma 2/2/2012 9:56:44 AM
AIBioTech Assists EUSA Pharma in Obtaining FDA Approval for a Critical Drug Product 11/22/2011 7:53:20 AM
EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE(TM) for Treatment of Acute Lymphoblastic Leukemia 11/18/2011 7:15:08 AM
EUSA Pharma Submits ERWINASE(R) Biologics License Application (BLA) for Treatment of Acute Lymphoblastic Leukemia 11/9/2010 11:24:29 AM
EUSA Pharma Announces the Appointment of Stephen A. Stamp to Its Board of Directors 9/1/2010 11:03:54 AM
EUSA Pharma Grants Japanese Rights To Erwinase(R) Oncology Therapy To Ohara Pharmaceutical 7/6/2010 2:32:48 PM
EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region 3/8/2010 7:17:33 AM